Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion
Sign Up to like & getrecommendations! Published in 2018 at "Advances in Rheumatology"
DOI: 10.1186/s42358-018-0016-x
Abstract: IntroductionInfliximab infusion generally occurs in 2–4 h. Recent studies have suggested the possibility of accelerated infusion (1 h) of this drug.ObjectiveTo evaluate the safety of accelerated infliximab infusion in patients with rheumatic diseases. In addition, patient satisfaction… read more here.
Keywords: satisfaction; rheumatic patients; infusion; safety ... See more keywords